Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.

Roman-Unfer S, Bitran JD, Garrison L, Proeschel C, Hanauer S, Schroeder L, Johnson L, Klein L, Martinec J. A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells. Exp Hematol. 1996 Jun; 24(7):823-8.

View in: PubMed

collapse authors with profiles